Pfizer and Merck have each won FDA approvals in the past year for new pneumococcal vaccines, but GSK aims to top both of them with its $2.1 billion acquisition of Affinivax. That biotech's Phase 3-ready vaccine candidate addresses more bacterial strains than any pneumococcal vaccines currently available.
In this podcast Mike Alkire discusses the importance of health systems achieving scale such that they are in a better position vis-a-vis payers who are typically much larger.
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities, plus showcase how your company is changing the future of digital health.
Roche drug Evrysdi, one of three FDA-approved treatments for spinal muscular atrophy, is now approved for treating those younger than age 2. The regulatory decision puts the oral drug on equal footing with SMA drugs from Novartis and Biogen.
Rates of anxiety, depression and suicidal ideation are high among the nation's youth, particularly girls and young women. Mental health app Most Days is combatting this crisis by providing users with healthy routines to follow, developed by mental health professionals with clinical expertise.
By Michael Schroeder Tuesday, May 31, 2022 1:58 PM
After finding success with a weight management program, BlueCross BlueShield of South Carolina expanded its employee wellness program developed by Solera Health to include mental health and musculoskeletal services.
No comments